With more than 14 randomized controlled trials, spanning more than a decade, it is no surprise that the AUA and EAU both support HoLAP and HoLEP as a first line procedure for the treatment of BPH. Precise and controlled cutting and ablation allows the holmium laser energy to penetrate just enough to ablate tissue without the charring, deep thermal necrosis or collateral damage often seen with other laser treatments.